Prospective Evaluation of the Carbon Footprint and Clinical Utility of Intestinal Bowel Ultrasound Compared to Colonoscopy and Enterography in Ulcerative Colitis and Crohn's Disease
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
Healthcare contributes approximately 4.4% of global GHG emissions, with diagnostic imaging and endoscopic services being substantial contributors. Colonoscopy and cross-sectional imaging modalities, though indispensable, are associated with high carbon emissions due to electricity use, waste, sterilisation, and transportation. IBUS, a non-invasive, real-time diagnostic modality, is increasingly validated for disease activity assessment in both UC and CD.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• All consecutive patients undergoing endoscopy procedures with consent for procedures, during the study period will be included
Locations
Other Locations
India
AIG Hospitals
RECRUITING
Hyderabad
Contact Information
Primary
Dr.Hardik Rughwani
dr.hardikr@aighospitals.com
9426928600
Time Frame
Start Date: 2026-03
Estimated Completion Date: 2026-12
Participants
Target number of participants: 200
Treatments
Ulcerative colitis
carbon footprint and clinical usefulness of Intestinal Bowel Ultrasound (IBUS) with standard imaging colonoscopy in patients with Ulcerative Colitis Colonoscopy+ IBUS
Crohns disease
carbon footprint and clinical usefulness of Intestinal Bowel Ultrasound (IBUS) with standard imaging CT/MRI enterography in patients with Crohn's Disease CT/MRI enterography+ IBUS
Related Therapeutic Areas
Sponsors
Leads: Asian Institute of Gastroenterology, India